Phospho-TCTP expression levels were reduced by treatment with BI 2536, a selective PLK1 inhibitor [35, 36], confirming that TCTP is phosphorylated by PLK1 in mammary carcinoma cells. Here, TPT1 is linked to breast carcinoma.